Serum Levels of Semaphorin 4C in Breast Cancer – Assessment of Prognostic Value and Potential for Monitoring Surgical Treatment Response

Popov Ts.; Maslyankov S.; Arabadzhiev A.; Sokolov M.; Kandilarova S.

doi:10.2478/amb-2024-0070

Acta Medica Bulgarica (Dec 2024)

Serum Levels of Semaphorin 4C in Breast Cancer – Assessment of Prognostic Value and Potential for Monitoring Surgical Treatment Response

Popov Ts.,
Maslyankov S.,
Arabadzhiev A.,
Sokolov M.,
Kandilarova S.

Affiliations

Popov Ts.: 1Medical University – Sofia, Bulgaria
Maslyankov S.: 1Medical University – Sofia, Bulgaria
Arabadzhiev A.: 1Medical University – Sofia, Bulgaria
Sokolov M.: 1Medical University – Sofia, Bulgaria
Kandilarova S.: 1Medical University – Sofia, Bulgaria

DOI: https://doi.org/10.2478/amb-2024-0070
Journal volume & issue: Vol. 51, no. 4
pp. 1 – 7

Abstract

Read online

Introduction. The global burden of breast cancer (BC) has encouraged ceaseless research in exploring novel biomarkers, aiming to optimize BC management and prognosis.

Published in Acta Medica Bulgarica

ISSN: 0324-1750 (Print); 2719-5384 (Online)
Publisher: Sciendo
Country of publisher: Poland
LCC subjects: Medicine
Website: https://sciendo.com/journal/AMB

About the journal

Abstract

Keywords